Managed Healthcare Executive2d
Study Explores Immunotherapy vs. Chemoimmunotherapy Decisions For Advanced Non-Small Lung Cancer
The researchers found that factors favoring chemoimmunotherapy included higher socioeconomic status, being uninsured, a more ...
China-Based Biotech BeiGene Scores FDA Approval For Tevimbra/Chemo Combo For Untreated Patients With Esophageal Cancer
BeiGene's Tevimbra wins FDA approval for first-line metastatic ESCC treatment, showing significant survival benefits in PD-L1 ...
Finely tuned large language models can extract PD-L1 biomarker details from electronic health records
A new study published in AI in Precision Oncology examines the ability of large language models (LLMs) to rapidly extract ...
Precision Medicine Online2d
FDA Approves BeiGene's Tevimbra in First-Line PD-L1-Positive Esophageal Cancers
Patients with PD-L1-positive tumors lived more than seven months longer on Tevimbra added to chemotherapy compared to just chemo.
Targeted Oncology3d
Understanding the Use of Nivolumab in the Current Upper GI Landscape
David Zhen, MD, discussed the relevance of nivolumab in the upper gastrointestinal cancer population. In an interview with ...
MPR2d
Tevimbra Plus Chemotherapy Approved as First-Line Tx for Advanced Esophageal Cancer
The Food and Drug Administration (FDA) has approved Tevimbra® (tislelizumab-jsgr), in combination with platinum-containing chemotherapy, for the ...
Targeted Oncology3d
FDA Approves Frontline Tislelizumab Plus Chemotherapy in Advanced ESCC
Tislelizumab plus chemotherapy is now FDA-approved for metastatic esophageal squamous cell carcinoma with a tumor PD-L1 ...
Los Angeles Times1d
ImmunityBio Receives FDA RMAT Designation for ANKTIVA and CAR-NK (PD-L1 t-haNK) to Achieve Reversal of Lymphopenia in Pancreatic Cancer Patients
Today’s designation of ANKTIVA and the first CAR-NK (PD-L1 T-haNK), both first-in-class molecules to activate lymphocytes within the body (via subcutaneous injection of ANKTIVA) and via ex-vivo ...
Oncology Nursing News3d
FDA Approves Tislelizumab Combo for Advanced ESCC
The FDA approved tislelizumab-jsgr (Tevimbra) with platinum chemotherapy as a first-line treatment for adults with ...
TMCnet1d
Ability of Large Language Models to Extract PD-L1 Biomarker Details From Electronic Health Records
"LLMs, fine-tuned with high-quality labeled data, accurately extracted complex PD-L1 test details from EHRs despite considerable variability in cancer type, documentation and time," reported the ...